1-β-D-Arabinofuranosyluracil

CAS : 3083-77-0

Ref. TR-A764000

Informations sur le produit

• Nom: 1-β-D-Arabinofuranosyluracil
• Synonymes: Arabinofuranosyluracil, Arabinosyluracil, Arauridine, NSC 68928, Spongouridin, Spongouridine, Uracil arabinoside, Cytarabine Imp. A (EP),Ara-U, 1-beta-d-arabinofuranosylpyrimidine-2,4(1H,3H)-dione (uracil arabonoside), Uracil, 1-beta-D-arabinofuranosyl- (6CI,7CI,8CI), 1-beta-D-Arabinofuranosyluracil, Uracil beta-D-arabinofuranoside, Nelarabine related, Uracil Arabinofuranoside, GR 46541X, 282U85, Cytarabine Impurity A, 1-(beta-D-arabinofuranosyl)pyrimidine-2,4(1H,3H)-dione, 1-?Arabinofuranosyluracil, 1-pentofuranosylpyrimidine-2,4(1H,3H)-dione, 1-β-<span class="text-smallcaps">D</span>-Arabinofuranosyl-2,4(1H,3H)-pyrimidinedione, 1-β-<span class="text-smallcaps">D</span>-Arabinofuranosyluracil, 2,4(1H,3H)-Pyrimidinedione, 1-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-, Arabinfuranosyluracil, Uracil β-<span class="text-smallcaps">D</span>-arabinofuranoside, Uracil, 1-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-, ara-U

Description

Impurity Cytarabine EP Impurity A
Applications Antiviral agent. Used for the treatment of severe acute respiratory syndrome (SARS).
References Weber, G., et al.: Cancer Res., 43, 3466 (1983), Broet, P., et al.: J. Clin. Oncol., 19, 2778 (2001), Galmarini, C., et al.: Leukemia, 15, 875 (2001), Barth, R., et al.: Cancer Res., 64, 6287 (2004), Song, M., et al.: Bioorg. Med. Chem., 12, 489 (2004),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 244.20
• Formule: C₉H₁₂N₂O₆
• Couleur/Forme: White
• InChI: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7+,8-/m1/s1
• Code InChI: InChIKey=DRTQHJPVMGBUCF-CCXZUQQUSA-N
• SMILES: O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]1